131 related articles for article (PubMed ID: 7524795)
1. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Nord CE; Lahnborg G
Eur J Surg Suppl; 1994; (573):45-9. PubMed ID: 7524795
[TBL] [Abstract][Full Text] [Related]
2. Effect of ciprofloxacin compared to gentamicin in the treatment of experimental intraabdominal infections in rats.
Lahnborg G; Nord CE
Scand J Infect Dis Suppl; 1989; 60():35-8. PubMed ID: 2756352
[TBL] [Abstract][Full Text] [Related]
3. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dactimicin plus clindamycin compared with gentamicin plus clindamycin in the treatment of experimental intra-abdominal infections in rats.
Nord CE; Lahnborg G
Drugs Exp Clin Res; 1990; 16(8):403-6. PubMed ID: 2097144
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tosufloxacin in the treatment of experimentally induced intra-abdominal infections in rats.
Nord CE; Edlund C
Drugs Exp Clin Res; 1992; 18(3):89-92. PubMed ID: 1425208
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Vestweber KH; Grundel E
Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
[TBL] [Abstract][Full Text] [Related]
7. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Shyr YM; Lui WY; Su CH; Wang LS; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Aug; 56(2):102-8. PubMed ID: 7553416
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of dactimicin in the treatment of experimentally induced intra-abdominal infections.
Nord CE; Lahnborg G
Drugs Exp Clin Res; 1989; 15(3):115-8. PubMed ID: 2752909
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Polk HC; Fink MP; Laverdiere M; Wilson SE; Garber GE; Barie PS; Hebert JC; Cheadle WG
Am Surg; 1993 Sep; 59(9):598-605. PubMed ID: 8396374
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats.
Nord CE; Lahnborg G
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():137-41. PubMed ID: 2732135
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats.
Nord CE; Lahnborg G
Drugs Exp Clin Res; 1992; 18(10):411-4. PubMed ID: 1306152
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP
J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin-tazobactam treatment for severe intra-abdominal infections.
Legrand JC; Bastin F; Belva P; Chastel C; Renaux J; Van Eukem P
Acta Chir Belg; 1995; 95(3):162-5. PubMed ID: 7610751
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
Sörgel F; Kinzig M
Eur J Surg Suppl; 1994; (573):39-44. PubMed ID: 7524794
[TBL] [Abstract][Full Text] [Related]
19. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
Nord CE
Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Nord CE; Edlund C; Lahnborg G
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():59-63. PubMed ID: 2872197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
